FINVX | LIDOX | FINVX / LIDOX | |
Total Expense Ratio | 0.01 | 0.66 | 2% |
Annual Report Gross Expense Ratio | 0.01 | 0.66 | 2% |
Fund Existence | 16 years | 8 years | - |
Gain YTD | 35.151 | 27.143 | 130% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.6B | 469M | 3,326% |
Annual Yield % from dividends | 3.67 | 3.12 | 118% |
Returns for 1 year | 29.72 | 23.56 | 126% |
Returns for 3 years | 80.69 | 56.97 | 142% |
Returns for 5 years | 117.54 | 70.75 | 166% |
Returns for 10 years | 99.65 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSCH | 40.10 | 0.26 | +0.66% |
Invesco S&P SmallCap Health Care ETF | |||
EPOL | 33.45 | 0.18 | +0.54% |
iShares MSCI Poland ETF | |||
BBEU | 68.72 | 0.22 | +0.32% |
JPMorgan BetaBuilders Europe ETF | |||
JMID | 29.33 | -0.17 | -0.59% |
Janus Henderson Mid Cap Growth Alpha ETF | |||
SQLV | 41.85 | -0.85 | -1.99% |
Royce Quant Small-Cap Quality Value ETF |